|
Status |
Public on Aug 15, 2019 |
Title |
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
We report that OTX015 upregulates BCL6 in KRAS-mutant NSCLC cells. Considering that both BCL6 and BET proteins regulate target genes by affecting transcription, we performed an RNA-seq experiment to identify downstream genes which response to OTX015. Retinal mRNA profiles of A549 cells treated with DMSO (0.1% for 6 hr) and OTX015 (1 μM for 6 hr) were generated by deep sequencing, in triplicate, using the SOLiD v4 sequencing platform. The sequence reads that passed quality filters were analyzed at the transcript isoform level with two methods: Burrows-Wheeler Aligner (BWA) followed by ANOVA (ANOVA) and TopHat followed by Cufflinks. qRT-PCR validation was performed using TaqMan and SYBR Green assays.
|
|
|
Overall design |
Retinal mRNA profiles of A549 treated with 1μM OTX015 for 6 hr or not were generated by deep sequencing, in triplicate, using the Illumina HiSeq 2500 sequencing platform.
|
|
|
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Aug 16, 2018 |
Last update date |
Aug 17, 2019 |
Contact name |
Lingyun Zheng |
E-mail(s) |
zhenglingyun@gdpu.edu.cn
|
Organization name |
Guangdong Pharmaceutical University
|
Department |
School of Life Sciences and Biopharmaceutics
|
Street address |
280 Wai Huan Dong Lu, Guangzhou Higher Education Mega Center
|
City |
Guangzhou |
State/province |
Guangdong |
ZIP/Postal code |
510006 |
Country |
China |
|
|
Platforms (1) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (6)
|
|
Relations |
BioProject |
PRJNA486332 |
SRA |
SRP158126 |